Life Sciences
Iluminos Therapeutics LLC
Year
2018
Illuminos Therapeutics has developed a series of novel small molecules for the treatment of Alzheimer’s disease and other neurodegenerative and cognitive diseases.
Company Status
Active
U of A Inventors
Chris Hulme
Travis Dunckley
Yeng Jeng Shaw
College
College of Pharmacy, BIO5 Institute